Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Stericycle Inc    SRCL

Delayed Quote. Delayed  - 07/27 10:00:00 pm
106.48 USD   -0.56%
07/26 STERICYCLE : Glancy Prongay & Murray Announces the Filing of a Secur..
07/22 Khang & Khang LLP Announces the Filing of a Securities Class Acti..
07/19 LAWSUIT FOR INV : SRCL) over Alleged Securities Laws Violations File..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales2 1432 5562 9863 6493 8904 123
Operating income (EBITDA)6457207899621 0631 184
Operating profit (EBIT)556615662772867941
Pre-Tax Profit (EBT)478-----
Net income311326255380459520
P/E ratio32,634,640,726,121,219,4
EPS ( $ )3,563,792,964,095,035,48
Dividend per Share ( $ )------
Yield------
Reference price ( $ )116.17131.08120.6106.48106.48106.48
Announcement Date02/05/2014
09:02pm
02/05/2015
09:02pm
02/04/2016
09:02pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt1 3691 6373 1581 1622 5822 278
Finance------
Operating income (EBITDA)6457207899621 0631 184
Leverage
(Debt/EBITDA)
2,12x2,27x4,00x1,21x2,43x1,92x
Capital Expenditure73,186,5115135141133
Book Value Per Share (BVPS)20,6 $22,4 $32,1 $33,1 $37,5 $42,7 $
Cash Flow per Share4,62 $5,20 $4,53 $5,64 $6,15 $6,85 $
Announcement Date02/05/2014
09:02pm
02/05/2015
09:02pm
02/04/2016
09:02pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 9 041 M$ -
Entreprise Value (EV) 10 203 M$ 11 624 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 26,1x 21,2x
Capitalization / Revenue 2,48x 2,32x
EV / Revenue 2,80x 2,99x
EV / EBITDA 10,6x 10,9x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 3,22x 2,84x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 21,2% 22,3%
operating Leverage (Delta EBIT / Delta Sales) 0,75x 1,86x
Net Margin (Net Profit / Revenue) 10,4% 11,8%
ROA (Net Profit / Asset) 26,8% 8,31%
ROE (Net Profit / Equities) 15,7% 15,7%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   3,70% 3,63%
Cash Flow / Sales 13,1% 13,4%
Capital Intensity (Assets / Sales) 0,39x 1,42x
Financial Leverage (Net Debt / EBITDA) 1,21x 2,43x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend